Directory Profile

Denise L. Howrie Schiff, PharmD

Office: 5472 Salk Hall, 3501 Terrace St, 15261

Phone: 412-624-9263

Pager: 412-692-7243 #2961


Denise L. Howrie is Associate Professor of Pharmacy and Therapeutics and of Pediatrics at the University of Pittsburgh Schools of Pharmacy and Medicine. She received a BS in Pharmacy from Duquesne University and earned the Doctor of Pharmacy degree from the University of Cincinnati, and has been a faculty member since 1978. Dr. Howrie also completed an ASHP Residency in Hospital Pharmacy at Cincinnati General Hospital. Dr. Howrie is a clinical pharmacy specialist at the Children’s Hospital of Pittsburgh of UPMC, serving in this role since 1978.

Dr. Howrie is the Assistant Dean for Academic Affairs and is the Program Director, Pediatric Area of Concentration in the Doctor of Pharmacy Program.  Dr. Howrie’s clinical practice focuses in pharmacotherapy in pediatrics, with specific emphasis in the pharmacy care of children with hematology-oncology diseases and hematopoietic stem cell therapy.  She initiated clinical pharmacy services at the Children’s Hospital of Pittsburgh and currently shares responsibilities for practice with 6 other clinicians, providing patient consultation, pharmacokinetic monitoring, adverse drug event management, drug information, and other services. 

She has been involved in drug use protocol development and is an active member of CHP Pharmacy & Therapeutics Committee and the University of Pittsburgh Institutional Research Board.  Dr. Howrie also serves as a consultant to the Children’s Oncology Group program at the Children’s Hospital of Pittsburgh at UPMC as well as the national Pediatric Brain Tumor Consortium.  Dr. Howrie is a member of the American Association of Colleges of Pharmacy, the Pediatric Pharmacy Advocate Group, the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists.  

Dr Howrie currently serves as Assistant Dean for Academic Affairs and is a member of the School's Office of Education and the PharmD Program Assessment Committee.